Thyroid Ultrasound: Nodules, TIRADS, and Preparation

Ecografía de Tiroides: Nódulos, TIRADS y Preparación
SEO TITLE: Thyroid Ultrasound: Nodules, TIRADS and Preparation META DESC: What thyroid ultrasound evaluates, how to prepare, the TIRADS system for classifying nodules and when to request a biopsy. Guide for Colombia. BLOG/SILO: thyroid-ultrasound-1 MAIN KEYWORD: thyroid ultrasound SECONDARY KEYWORDS: thyroid ultrasound, thyroid ultrasound, TIRADS thyroid nodules, thyroid ultrasound preparation COLORS: --c1:#1a4b8c; --c2:#2563eb TYPE: IN-DEPTH --> Thyroid Ultrasound: Nodules, TIRADS and Preparation
Ultrasound and Sonography

Thyroid Ultrasound: Nodules, TIRADS System and How to Prepare

Everything you need to know about thyroid ultrasound: what it evaluates, how a nodule is classified with TIRADS and when the endocrinologist requests a biopsy.

Reviewed by diagnostic imaging specialists · GSMED Imaging Colombia

Thyroid ultrasound —also called thyroid ultrasound or thyroid sonography— is the first-line imaging study to evaluate the thyroid gland and the lymph nodes of the neck. It is the most sensitive method to detect thyroid nodules, determine their characteristics and guide clinical decision-making: observe, biopsy or refer to surgery.

In Colombia, the prevalence of thyroid nodules detectable by ultrasound exceeds 50% in adults over 50 years old. The vast majority are benign, but ultrasound —and especially the TIRADS classification system— allows the doctor to identify which ones warrant a biopsy and which ones only require follow-up.

What does thyroid ultrasound evaluate?

The thyroid is a superficial gland located in the anterior part of the neck, which makes it ideal for ultrasound. The high-frequency probe allows for highly detailed images without radiation. The parameters that are systematically evaluated are:

Gland size and volume

The three axes of each lobe and the isthmus are measured. The normal total volume is 8–18 ml in adults. Higher values indicate goiter.

Parenchymal echostructure

Homogeneous or heterogeneous. Diffuse reduced echogenicity suggests autoimmune thyroiditis (Hashimoto). Nodular pattern in multinodular goiter.

Nodule characterization

Composition (solid/cystic/mixed), echogenicity, shape, margins, calcifications and size. These are the criteria of the TIRADS system.

Vascularization (Doppler)

Intranodular and perinodular flow. "Thyroid hell" (diffuse hypervascularization) is typical of Graves' disease. Hypervascularized nodules may require additional attention.

Cervical lymph nodes

Evaluation of lymph node chains to detect metastasis in cases of suspicious nodules or known thyroid carcinoma.

How to prepare for thyroid ultrasound

Preparation is minimal. The thyroid gland is superficial and its image does not depend on the digestive state or the bladder. Even so, there are some practical points that improve the quality of the exam:

✅
Fasting is not required

You can eat and drink normally before the exam.

💍
Remove jewelry from the neck

Necklaces, chains and long earrings should be removed to facilitate probe access.

👕
Wear clothing with an open neck

Avoid turtlenecks or closed shirts. Loose clothing facilitates positioning.

📋
Bring previous studies

If there are previous ultrasounds, bring them to compare the size and evolution of the nodules.

💊
Report thyroid medications

Levothyroxine, propylthiouracil or other drugs that may modify the ultrasound image.

⏱️
Duration: 15–20 minutes

The exam is fast, painless and without side effects. The conductive gel may be cold.

💡 Tip: The patient is positioned in supine decubitus with the neck in slight hyperextension (pillow under the shoulders). This position better exposes the gland and facilitates the exploration of the lower poles.

TIRADS System: thyroid nodule classification

ACR-TIRADS (Thyroid Imaging Reporting and Data System) was developed by the American College of Radiology to standardize the description of thyroid nodules and guide the biopsy decision. It assigns points according to five ultrasound characteristics:

COMPOSITION

Cystic=0 · Spongiform=0 · Mixed=1 · Solid=2

ECHOGENICITY

Anechoic=0 · Hyperechoic=1 · Isoechoic=2 · Hypoechoic=3

SHAPE

Wider than tall=0 · Taller than wide=3

MARGINS

Regular=0 · Indefinite=0 · Lobulated=2 · Spiculated=3

CALCIFICATIONS

None=0 · Coarse=1 · Peripheral=2 · Punctate=3

The sum of points defines the TIRADS category from 1 to 5:

TIRADS Points Description Malignancy risk Recommended management
TR1 0 Normal thyroid, no nodules ~0% No specific follow-up
TR2 0 Benign nodule (simple cyst, spongiform) <2% No biopsy. Optional follow-up
TR3 3 Slightly suspicious ~5% Biopsy if ≥2.5 cm · Follow-up if ≥1.5 cm
TR4 4–6 Moderately suspicious 5–20% Biopsy if ≥1.5 cm · Follow-up if ≥1 cm
TR5 ≥7 Highly suspicious of malignancy >20% Biopsy if ≥1 cm · Follow-up if ≥0.5 cm

* ACR-TIRADS 2017 criteria. The final management is determined by the endocrinologist or thyroid surgeon based on the complete clinical context.

When is a biopsy requested (ultrasound-guided FNA)?

Ultrasound-guided fine-needle aspiration (FNA) is the standard procedure for obtaining cells from a suspicious nodule and analyzing them under a microscope. Real-time ultrasound guidance increases diagnostic accuracy and reduces unsatisfactory samples.

Indications for FNA according to ACR-TIRADS

  • TR5TIRADS 5: Biopsy if the nodule measures ≥ 1 cm. Follow-up if it measures 0.5–0.9 cm.
  • TR4TIRADS 4: Biopsy if the nodule measures ≥ 1.5 cm. Follow-up if it measures 1–1.4 cm.
  • TR3TIRADS 3: Biopsy if the nodule measures ≥ 2.5 cm. Follow-up if it measures 1.5–2.4 cm.

The procedure is outpatient and performed under local anesthesia. With real-time ultrasound guidance, the radiologist directs a fine needle directly into the nodule, aspirates cells, and sends them to a pathologist for cytological analysis (Bethesda system). The result is usually available in 3–7 business days.

💡 Important: A TIRADS 3 or 4 result does not mean cancer. The vast majority of these nodules turn out to be benign on biopsy. The goal of TIRADS is precisely to avoid unnecessary biopsies of low-risk nodules.

Common findings on thyroid ultrasound

🔵 Simple or multinodular goiter

Diffuse or nodular enlargement of the gland. Multinodular goiter is very common in Colombia due to historical iodine deficiency in some regions. Ultrasound measures the volume and maps the nodules.

🟣 Hashimoto's thyroiditis

Diffusely heterogeneous and hypoechoic echostructure, with a "mottled" appearance. It is the most frequent cause of hypothyroidism in Colombia. Ultrasound supports the diagnosis along with anti-TPO antibodies.

🟡 Benign colloid nodule

The most frequent type. Spongiform appearance or with "comet tail" artifacts. TIRADS 2: no biopsy required. Follow-up only if it grows significantly (>20% in two dimensions).

🟢 Graves' disease (hyperthyroidism)

Intense diffuse hypervascularization ("thyroid inferno") on color Doppler, with an enlarged gland and hypoechoic parenchyma. It correlates with suppressed TSH and TSH-R antibodies.

🔴 Nodule suspicious of malignancy

Hypoechoic solid, taller than wide, spiculated margins, punctate calcifications (microcalcifications). Features associated with papillary thyroid carcinoma, the most frequent.

🔵 Simple thyroid cyst

Completely anechoic lesion, with thin walls, without a solid component. TIRADS 2: benign by definition. Only treated if they cause compressive symptoms.

Ultrasound equipment for thyroid

The key to a quality thyroid ultrasound is the high-frequency linear probe. Unlike other regions that require low-frequency convex probes for greater penetration, the thyroid is superficial and benefits from high frequencies that offer greater spatial resolution.

STANDARD PROBE

Linear 7.5–12 MHz

Suitable for most thyroid studies. Good resolution to characterize medium-large nodules and evaluate the glandular parenchyma.

HIGH RESOLUTION

Linear 12–15 MHz

Recommended for microcalcification detection (1–2 mm), nodules smaller than 5 mm, and cervical lymph node evaluation. Standard in specialized endocrinology centers.

WITH COLOR DOPPLER

Mindray TE/Resona series

Mindray equipment with L12-4 and L14-6N linear probes offers high-sensitivity color Doppler, ideal for characterizing intra- and perinodular vascularization and guiding FNA procedures.

Do you need equipment with high-frequency probes for thyroid?

At GSMED Imaging, we are authorized Mindray distributors in Colombia. We advise on the selection of equipment and probes according to the specialty: endocrinology, radiology, and internal medicine.

Request advice →

Frequently Asked Questions about Thyroid Ultrasound

The most common questions from patients and professionals.

Does thyroid ultrasound hurt?

No. It is completely painless. You only feel the cold conductive gel at the beginning and slight pressure from the probe on the neck. It does not require anesthesia or sedation.

Does thyroid ultrasound require fasting?

No. Unlike abdominal ultrasound, the thyroid study does not depend on the digestive state. You can eat and drink normally. You are only asked to remove jewelry from the neck and wear clothing with an accessible neckline.

Does a TIRADS 3 nodule mean I have cancer?

No. TIRADS 3 indicates a low-risk category with approximately a 5% probability of malignancy. The vast majority are benign. The TIRADS system helps identify which ones deserve a biopsy (generally those larger than 2.5 cm) and which only need follow-up.

What is the difference between thyroid ultrasound and scintigraphy?

Ultrasound uses ultrasound and evaluates the morphology, size, and structural characteristics of the thyroid and its nodules. Thyroid scintigraphy uses a radiopharmaceutical (radioactive iodine or technetium) and evaluates the function of the gland, identifying "cold" nodules (do not capture = greater suspicion) or "hot" nodules (hyperfunctioning = lower suspicion of malignancy). They are complementary, not mutually exclusive.

How often should I repeat the thyroid ultrasound?

It depends on the finding. For TIRADS 3 nodules (≥1.5 cm): follow-up at 1, 3, and 5 years. For TIRADS 4 (≥1 cm): follow-up at 1 and 2 years. For patients with Hashimoto's thyroiditis without nodules: every 1–2 years or as indicated by the endocrinologist. Nodules that grow >20% in two dimensions warrant re-evaluation regardless of the category.

SCHEMA JSON-LD — PASTE IN SHOPIFY -->
Subscribe Us
Subscribe to our newsletter and receive a selection of cool articles every weeks